Key Takeaways
- Citi’s Atif Malik launched coverage of CBRS with a Buy recommendation and the highest Wall Street price target of $340, suggesting 45.9% potential appreciation.
- Craig-Hallum initiated coverage with a Buy rating and $325 target, highlighting Cerebras’ wafer-scale architecture as superior to rival AI inference platforms.
- Shares of CBRS declined 3.09% on Tuesday, bringing total losses to 23.54% from its May 14 IPO price of $350.
- Major partnerships with OpenAI and Amazon over the past six months signal growing industry confidence in Cerebras’ technology.
- Analyst consensus stands at Strong Buy across 10 ratings, with an average price target of $294 — representing approximately 27.69% upside potential.
Cerebras Systems (CBRS) made its public market debut on May 14, 2026, at an initial price of $350 per share. In the weeks following, shares have retreated 23.54%, hovering near $233 as of Tuesday’s close.
The post-IPO pullback hasn’t dampened Wall Street enthusiasm, however.
Citi analyst Atif Malik launched coverage with a Buy recommendation and established the Street’s most aggressive price objective at $340. From current trading levels, that implies upside potential of approximately 46%.
Craig-Hallum also jumped in with a Buy rating, setting their target at $325. The firm emphasized Cerebras’ proprietary wafer-scale computing platform, which they believe outpaces all competing AI inference solutions in terms of processing speed.
Cerebras pioneered wafer-scale computing technology — creating a processor that utilizes an entire silicon wafer instead of dividing it into separate chips.
Malik’s analysis projects Cerebras will command between 40% and 50% market share in fast inference applications. With his total addressable market estimate of $130 billion, that translates to potential annual revenue ranging from $52 billion to $65 billion.
Craig-Hallum offers an even more optimistic outlook for the AI inference sector — forecasting the market will exceed $250 billion by decade’s end.
Industry Giants Validate Technology
Both OpenAI and Amazon have chosen Cerebras as their inference provider within the past six months. According to Craig-Hallum, these partnerships demonstrate to the broader market that Cerebras represents a credible challenger to established solutions.
The firm emphasized that processing speed has emerged as a critical competitive factor in AI applications — referencing recent model releases that command premium pricing specifically for accelerated response capabilities.
Cerebras generated $510 million in trailing twelve-month revenue, marking 76% year-over-year growth. The company has already achieved profitability.
This combination of rapid growth and positive earnings is uncommon among recent IPOs.
Widespread Analyst Support
Numerous additional firms launched coverage alongside Citi and Craig-Hallum.
Needham assigned a Buy rating with a $300 price objective, emphasizing Cerebras’ exclusive market position as the only provider of Wafer-Scale Engines. Rosenblatt similarly rated it Buy at $300, calling attention to performance gains from the company’s third-generation platform.
Wedbush initiated with an Outperform rating and $270 target. Mizuho matched the Outperform assessment while setting a $300 objective. Barclays established an Overweight rating with a $280 target.
Among all 10 analysts covering the stock, the consensus rating is Strong Buy. The mean price target across all firms stands at $294.
Tuesday’s trading activity was relatively light at approximately 1.75 million shares, significantly below the stock’s recent daily average of about 25 million.
Barclays specifically identified the OpenAI and Amazon partnerships as transformative developments for Cerebras within the competitive AI semiconductor landscape.
